Recce Pharmaceuticals Announces Multiple Patients Dosed with RECCE® 327 in Topical Phase I/II Clinical Trial for the Treatment of Infected Burn Wounds

NEXT STORY
The global pharmaceutical packaging market size is projected to reach USD 196.8 billion by 2026 from USD 99.9 billion in 2021, at a CAGR of 14.5%
PREV STORY
Global Residential Air Purification Equipment Market to Reach US$13 Billion by the Year 2027
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioCryst Pharmaceuticals Commences Public Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) ...

author_avatar
NASDAQ Market News

Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

MINNEAPOLIS, May 10, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, ...

author_avatar
NASDAQ Market News